A Novel Serine/Threonine Kinase Binding the Ras-related RhoA GTPase Which Translocates the Kinase to Peripheral Membranes
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
We previously reported the cloning of a serine/threonine kinase, PAK (for p21 (Cdc42/Rac)-activated kinase), which binds to the Ras-related GTPases Cdc42Hs and Rac1 (Manser, E., Leung, T., Salihuddin, H., Zhao, Z-s., and Lim, L. (1994) Nature 367, 40-46). These p21 proteins together with RhoA comprise the Rho subfamily of proteins that are involved in morphological events. We now report the isolation of a rat cDNA encoding a 150-kDa protein, which specifically binds RhoA in its GTP form and contains an N-terminal serine/threonine kinase domain highly related to the human myotonic dystrophy kinase and a cysteine-rich domain toward the C terminus. The RhoA binding domain is unrelated to other p21 binding domains. Antibody raised against the kinase domain of the predicted protein, termed ROK alpha (for ROK alpha, RhoA-binding kinase), recognized a ubiquitous 150-kDa protein. The brain p150 purified by affinity chromatography with RhoA exhibited serine/threonine kinase activity. In cultured cells, immunoreactive p150 was recruited to membranes upon transfection with dominant positive RhoAV14 mutant and was localized with actin microfilaments at the cell periphery. These results are consistent with a role for the kinase ROK alpha as an effector for RhoA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ridley, A. J., & Hall, A. (1992) · Cell · doi:10.1016/0092-8674(92)90163-7 · Cited by 4,468
Nobes, C. D., & Hall, A. (1995) · Cell · doi:10.1016/0092-8674(95)90370-4 · Cited by 4,412
The small GTP-binding protein rac regulates growth factor-induced membrane ruffling
Ridley, A. J., Paterson, H. F., Johnston, C. L., Diekmann, D., & Hall, A. (1992) · Cell · doi:10.1016/0092-8674(92)90164-8 · Cited by 3,652
Brook, J. D., McCurrach, M. E., Harley, H. G., Buckler, A. J., Church, D., Aburatani, H., Hunter, K., Stanton, V. P., Thirion, J.-P., Hudson, T., et al. (1992) · Cell · doi:10.1016/0092-8674(92)90154-5 · Cited by 2,777
A brain serine/threonine protein kinase activated by Cdc42 and Rac1
Manser, E., Leung, T., Salihuddin, H., Zhao, Z.-S., & Lim, L. (1994) · Nature · doi:10.1038/367040a0 · Cited by 1,538
Self-citationAn Unstable Triplet Repeat in a Gene Related to Myotonic Muscular Dystrophy
Fu, Y. H., Pizzuti, A., Fenwick, R. G., King, J., Rajnarayan, S., Dunne, P. W., Dubel, J., Nasser, G. A., Ashizawa, T., de Jong, P., et al. (1992) · Science · doi:10.1126/science.1546326 · Cited by 1,455
Kozma, R., Ahmed, S., Best, A., & Lim, L. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.4.1942 · Cited by 1,021
Self-citationJustice, R. W., Zilian, O., Woods, D. F., Noll, M., & Bryant, P. J. (1995) · Genes & Development · doi:10.1101/gad.9.5.534 · Cited by 977
Microinjection of recombinant p21rho induces rapid changes in cell morphology.
Paterson, H. F., Self, A. J., Garrett, M. D., Just, I., Aktories, K., & Hall, A. (1990) · The Journal of cell biology · doi:10.1083/jcb.111.3.1001 · Cited by 718
Cloning, expression, and transcriptional properties of the human enhancer factor TEF-1
Xiao, J. H., Davidson, I., Matthes, H., Garnier, J.-M., & Chambon, P. (1991) · Cell · doi:10.1016/0092-8674(91)90088-g · Cited by 419
Cited by
Items 101–112 of 112
Persidsky, Y., Heilman, D., Haorah, J., Zelivyanskaya, M., Persidsky, R., Weber, G. A., Shimokawa, H., Kaibuchi, K., & Ikezu, T. (2006) · Blood · doi:10.1182/blood-2005-11-4721 · Cited by 200
“The best-characterized effectors of Rho include RhoK, which is involved in the regulation of actin organization, cellular morphology, and cellular transformation.(26,55,56) A number of studies demonstrated Rho participation in endothelial cell function.”
BackgroundCitron binds to PSD-95 at glutamatergic synapses on inhibitory neurons in the hippocampus
Zhang, W., Vazquez, L., Apperson, M., & Kennedy, M. B. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-01-00096.1999 · Cited by 190
“A predicted protein serine/threonine kinase encoded in the Caenorhabditis elegans genome (GenBank accession number U97001) also appears to be a member of this family, as does Rho-associated kinase (ROK-a) (Leung et al., 1995), Rho-kinase (Matsui et al.”
BackgroundRhoE Regulates Actin Cytoskeleton Organization and Cell Migration
Guasch, R. M., Scambler, P., Jones, G. E., & Ridley, A. J. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.8.4761 · Cited by 181
RhoA-ROCK Signaling as a Therapeutic Target in Traumatic Brain Injury
Mulherkar, S., & Tolias, K. F. (2020) · Cells · doi:10.3390/cells9010245 · Cited by 179
Sculpting Organs: Mechanical Regulation of Tissue Development
Nelson, C. M., & Gleghorn, J. P. (2012) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071811-150043 · Cited by 130
A selective ROCK inhibitor, Y27632, prevents dimethylnitrosamine-induced hepatic fibrosis in rats
Tada, S., Iwamoto, H., Nakamuta, M., Sugimoto, R., Enjoji, M., Nakashima, Y., & Nawata, H. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(00)00059-3 · Cited by 102
Inhibition of Rho kinases enhances the degradation of mutant huntingtin
Bauer, P. O., Wong, H. K., Oyama, F., Goswami, A., Okuno, M., Kino, Y., Miyazaki, H., & Nukina, N. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m809229200 · Cited by 102
Rho-kinase as a target for cancer therapy and its immunotherapeutic potential
Kim, S., Kim, S. A., Han, J., & Kim, I.-S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312916 · Cited by 88
Salanova, M., Gelfi, C., Moriggi, M., Vasso, M., Viganò, A., Minafra, L., Bonifacio, G., Schiffl, G., Gutsmann, M., Felsenberg, D., et al. (2014) · The FASEB Journal · doi:10.1096/fj.14-252825 · Cited by 68
Nishimura, Y., Itoh, K., Yoshioka, K., Tokuda, K., & Himeno, M. (2003) · Pathology & Oncology Research · doi:10.1007/bf03033750 · Cited by 36
Nishimura, Y., Itoh, K., Yoshioka, K., Ikeda, K., & Himeno, M. (2002) · The Histochemical Journal · doi:10.1023/a:1021702812146 · Cited by 24
“…found to be impeded by the presence of Y-27632 (Uehata et al. 1997), a selective inhibitor of Rho-associated protein kinase p160ROCK which has been demonstrated to be a downstream target of RhoA (Leung et al. 1995, Matsui et al. 1996, Nakagawa et al. 1996, Amano et al. 1997, Ishizaki et al. 1997).”
BackgroundNishimura, Y., Itoh, K., Yoshioka, K., Uehata, M., & Himeno, M. (2000) · Cell and Tissue Research · doi:10.1007/s004410000243 · Cited by 22
Metadata
- Authors
- Leung, T., Manser, E., Tan, L., & Lim, L.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1995-12
- Volume
- 270
- Issue
- 49
- Pages
- 29051-29054
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2083822658
- Cited by
- 719
- References
- 22
- FWCI
- 13.38
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.